| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Jan 25 | ALXO ALX Oncology | Stock Option Common Stock | Grant | Acquire A | No | No | 1.65 | 40,400 | 66.66 k | 40,400 |
| 23 Sep 24 | TCRX TScan Therapeutics | Voting Common Stock | Buy | Acquire P | No | No | 5.29 | 5,000 | 26.45 k | 45,000 |
| 26 Aug 24 | TCRX TScan Therapeutics | Voting Common Stock | Buy | Acquire P | No | No | 5.53 | 5,000 | 27.65 k | 40,000 |
| 23 Aug 24 | TCRX TScan Therapeutics | Voting Common Stock | Buy | Acquire P | No | No | 5.69 | 5,000 | 28.45 k | 35,000 |
| 13 Jun 24 | EFTR eFFECTOR Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.38 | 800 | 1.10 k | 800 |
